Related to Aura Raises $4.5M and Signs CRADA for Diagnostic and Therapeutic Nanoparticle Platform

• MonoSol and Midatech Establish JV to Develop Transbuccal Nanoparticle Insulin Film
  
• Morphotek Acquires TransMolecular’s Tumor-Targeting Drug Delivery Assets
  
• Alnylam Extends RNAi Alliance with UBC and AlCana Technologies
  
• Scientists Develop High-Capacity Nanoparticles for Targeted Delivery of Drug Cocktails
  
• Precision NanoSystems and Alnylam Ally to Enhance RNAi Delivery
  
• Researchers Engineer Cells’ Own Vault Nanoparticles to Deliver Cytotoxic Drugs
  
• MDxHealth and NovioGendix Win $1.1M Grant to Develop Bladder Cancer Diagnostic
  
• BMS Expands Deal to Evaluate Tekmira’s RNAi Delivery Technology
  
• Scientists Develop Nanoparticles Cloaked with Erythrocyte Membranes
  
• Scientists Develop Communicating Nanoparticles that Boost Targeted Drug Delivery to Tumors
  
• Eureka Wins $750K SBIR Grant to Develop Technology for Detecting Anthrax Variants
  
• Selecta Wins SAIC Subcontract to Develop Synthetic Nanoparticle Malaria Vaccine
  
• NeuroVive and to-BBB Get €1M Boost to Stroke Therapy Collaboration
  
• Nanotherapeutics Wins $4.8M Contract for Oral Chelating Agent against Radiation Exposure
  
• Ablitech Gets $2M DoD Grant for R&D into Heterotopic Ossification
  
• QuantuMDx Licenses Nanosys’ Nanostructures for Use in Handheld Diagnostic Platform
  
• CureVac, Sanofi Pasteur, and In-Cell-Art Collaborate on €33.1M DARPA-Supported Vaccine Program
  
• GenomeQuest Awards $120K in Grants to Support NGS-Based Diagnostics
  
• Exosome, LMU Awarded €1M to Develop Blood-Based Exosome Diagnostics for Cancer
  
• Cynvenio Awarded Two SBIR Contracts to Develop Lung Cancer Assays Using CTC Platform